Soluble vascular endothelial growth factor (sVEGF) and the risk of venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study (CATS) - Posch, F; Thaler, J; Zlabinger, G-J (Clin Cancer Res, 2016)
, et al.